Results 141 to 150 of about 14,137,188 (298)

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development. [PDF]

Int J Dermatol
de Nicolas-Ruanes B, Fernandez-Lozano C, Gutierrez-Canales P, Ballester-Martinez A, Rodriguez-Otero N, Martinez-Botas J, de la Hoz Caballer B, Andres-Martin A, Solano-Solares E, Gomez-Salazar Lopez-Silanes ME, Diaz-Montalvo LG, Arrebola DM, Stewart-Delcid VL, Garcia-Mouronte E, Azcarraga-Llobet C, Berna-Rico E, Ortega-Sanchez S, Fernandez-Guarino M.   +17 more
europepmc   +1 more source

Non-Immediate Type Hypersensitivity Reactions with First-Line Antituberculosis Drugs and Diagnostic Patch Testing

Gözde Köycü Buhari, Sakine Nazik Bahçecioğlu, Selcan Gültuna, Dilek Çuhadar Erçelebi, Şenay Demir, Hatice Çelik Tuğlu, Onur Telli, Kurtuluş Aksu   +7 more
openalex   +1 more source

The Results of Patch Testing in Patients with Contact Dermatitis in Eastern Turkey

, 2011
Ömer Çalka, Ayşe Serap Karadağ, Necmettın Akdeniz, Serap Güneş Bilgili   +3 more
openalex   +1 more source

Uniprot datasets with variable patch sizes for testing taxonomic classification

, 2020
Benjamin Voigt, Oliver Fischer, Christian Krumnow, Christian Herta, Piotr Wojciech Dąbrowski   +4 more
openalex   +1 more source

Performance of Kansas State University’s Cold and Large Patch-Tolerant Zoysiagrasses in the National Turfgrass Evaluation Program Test

, 2021
Jack D. Fry, Manoj Chhetri
openalex   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Prevalence of positivity in patch tests and reactivity to substances present in the main dressings in patients with chronic leg ulcers. [PDF]

An Bras Dermatol
de Oliveira Mesquita ÍF, Pierri Carvalho Fonseca L, Rita Parise Fortes M, Amante Miot H, Patricia Fernandes Abbade L.   +4 more
europepmc   +1 more source

Positivity of contact dermatitis patch tests in an allergy and immunology dermatology service [PDF]

World Allergy Organ J, 2015
Mendes K, Castro A, Amaral C, Alonso M, Seiler T, Oliveira M, Silva E.   +6 more
europepmc   +1 more source

The role of the patch test in 2D atomistic-to-continuum coupling methods [PDF]

, 2011
Christoph Ortner
openalex   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source